“NICE To Know: An Update on the National Institute for Clinical Excellence Guidelines” Symposium

Co-sponsored by the Pharmaceutical Research Manufacturers Association (PhRMA) Health Outcomes Committee and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)

Supported by funding from: Amgen, Inc AstraZeneca Aventis Pharmaceuticals Bristol-Myers Squibb Eli Lilly and Company GlaxoSmithKline Johnson & Johnson Pfizer Pharmaceuticals Pharmacia Merck Research Laboratories Novartis Pharmaceuticals Roche Pharmaceuticals Wyeth-Ayerst Research   Program NICE Guidelines: A Methodological Basis for Decision Making NICE Guidelines: The Current Guidelines And What To Expect In The Future Pharmaceutical Perspective of the NICE Guidelines